Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Ghasemzad M, Hashemi M, Lavasani ZM, Hossein-Khannazer N, Bakhshandeh H, Gramignoli R, Keshavarz Alikhani H, Najimi M, Nikeghbalian S, Vosough M

Open source

DOI
10.3390/bioengineering9080392
Published
2022 Aug 15
Container
Bioengineering (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/bioengineering9080392,
  title = {Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.},
  author = {Ghasemzad M and Hashemi M and Lavasani ZM and Hossein-Khannazer N and Bakhshandeh H and Gramignoli R and Keshavarz Alikhani H and Najimi M and Nikeghbalian S and Vosough M},
  year = {2022},
  journal = {Bioengineering (Basel, Switzerland)},
  doi = {10.3390/bioengineering9080392},
  url = {https://doi.org/10.3390/bioengineering9080392}
}

RIS

TY  - JOUR
TI  - Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.
AU  - Ghasemzad M
AU  - Hashemi M
AU  - Lavasani ZM
AU  - Hossein-Khannazer N
AU  - Bakhshandeh H
AU  - Gramignoli R
AU  - Keshavarz Alikhani H
AU  - Najimi M
AU  - Nikeghbalian S
AU  - Vosough M
PY  - 2022
JO  - Bioengineering (Basel, Switzerland)
DO  - 10.3390/bioengineering9080392
UR  - https://doi.org/10.3390/bioengineering9080392
ER  - 

APA

M, G., M, H., ZM, L., N, H., H, B., R, G., H, K. A., M, N., S, N., & M, V. (2022). Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.. Bioengineering (Basel, Switzerland). https://doi.org/10.3390/bioengineering9080392

Source records